Fierce Pharma Biopharma News & Insights
网页Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
The top 10 most profitable pharma companies in 2021
网页The six largest drugmakers by 2021 revenue—J&J, Pfizer, Roche, AbbVie, Novartis and Merck & Co.—all made the top profit list but in quite a different order.
Top 20 Pharmaceutical Companies by Revenue 2021 | FiercePharma
网页2021年3月29日 · The pharma industry quickly took center stage when COVID-19 caught the world off guard early last year. As 2020 progressed, drugmakers battled the coronavirus on one hand and on the other ...
Pharma | Fierce Pharma
网页2 天之前 · The long-acting HIV PrEP maker pledged at least 2 million doses for low-and middle-income countries in 2025 and 2026. Zoey Becker Oct 7, 2024 10:56am. Connect.
Top 20 pharma companies by 2023 revenue - Fierce Pharma
网页2024年4月15日 · J&J was No. 1 in 2023 by a comfortable margin over No. 2 Roche, which raked in sales of $58.7 billion Swiss francs ($67 billion) last year. J&J’s big lead is especially noteworthy considering ...
Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of ...
网页2018年9月28日 · The loss of Cialis comes during a major time of transformation for Lilly. During its second-quarter earnings report in July, the company announced that it will spin off its animal health unit ...
The top 10 vaccine companies worldwide - Fierce Pharma
网页2022年10月17日 · What a difference five years—and a global pandemic—can make in reshaping an industry. When Fierce Pharma last published our rankings of the top vaccine players back in 2017, we highlighted the ...
The top 15 blockbuster patent expirations coming this decade
网页The biggest names set to face generic pressure in the coming years include the top four of the industry’s best-selling drugs in 2020: Humira, Keytruda, Revlimid and Eliquis. In all, nine of the ...
Generic Vyvanse cleared by FDA Amid shortage | Fierce Pharma
网页2023年8月30日 · A 100-day supply of the branded drug goes for $1,305, according to Drugs.com. Meanwhile, 30 capsules are priced at around $460. Takeda's Vyvanse shortage emerged after Adderall and its generics ...
Lilly's Mounjaro back in stock amid heightened obesity interest
网页2023年2月22日 · The Novo obesity drug recently resolved a supply issue, even though it’s still listed as in shortage by the FDA as of January. Lilly’s own GLP-1 drug, Trulicity, is also in short supply. The ...